Business Description
KORU Medical Systems Inc
NAICS : 339112
SIC : 3841
ISIN : US7599101026
Total Employee Number:
73Description
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.61 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.2 | |||||
Debt-to-EBITDA | -1.87 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 10.98 | |||||
Beneish M-Score | -2.92 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.8 | |||||
3-Year EBITDA Growth Rate | 40.8 | |||||
3-Year FCF Growth Rate | 60.8 | |||||
3-Year Book Growth Rate | -18.9 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 16.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 74.3 | |||||
9-Day RSI | 69.54 | |||||
14-Day RSI | 64.95 | |||||
3-1 Month Momentum % | -7.31 | |||||
6-1 Month Momentum % | -30.07 | |||||
12-1 Month Momentum % | 7.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.33 | |||||
Quick Ratio | 1.82 | |||||
Cash Ratio | 0.99 | |||||
Days Inventory | 87.74 | |||||
Days Sales Outstanding | 47.53 | |||||
Days Payable | 43.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.7 | |||||
Shareholder Yield % | 0.23 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 61.93 | |||||
Operating Margin % | -5.99 | |||||
Net Margin % | -5.27 | |||||
EBITDA Margin % | -4.16 | |||||
FCF Margin % | 0.27 | |||||
OCF Margin % | 1.65 | |||||
ROE % | -13.68 | |||||
ROA % | -8.34 | |||||
ROIC % | -22.2 | |||||
3-Year ROIIC % | -78.04 | |||||
ROC (Joel Greenblatt) % | -24.65 | |||||
ROCE % | -13.24 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 4.72 | |||||
PB Ratio | 12 | |||||
Price-to-Tangible-Book | 12.69 | |||||
Price-to-Free-Cash-Flow | 4440 | |||||
Price-to-Operating-Cash-Flow | 296.01 | |||||
EV-to-EBIT | -76.57 | |||||
EV-to-Forward-EBIT | 27.67 | |||||
EV-to-EBITDA | -110.24 | |||||
EV-to-Forward-EBITDA | 16.51 | |||||
EV-to-Revenue | 4.59 | |||||
EV-to-Forward-Revenue | 4.2 | |||||
EV-to-FCF | 1711.54 | |||||
Price-to-GF-Value | 1.09 | |||||
Price-to-Median-PS-Value | 1.05 | |||||
| Price-to-Net-Current-Asset-Value | 23.39 | |||||
Earnings Yield (Greenblatt) % | -1.31 | |||||
FCF Yield % | 0.06 | |||||
Forward Rate of Return (Yacktman) % | -18.38 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:KRMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
KORU Medical Systems Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 43.257 | ||
| EPS (TTM) ($) | -0.05 | ||
| Beta | 1.1907 | ||
| 3-Year Sharpe Ratio | 0.3 | ||
| 3-Year Sortino Ratio | 0.53 | ||
| Volatility % | 60.15 | ||
| 14-Day RSI | 64.95 | ||
| 14-Day ATR ($) | 0.196526 | ||
| 20-Day SMA ($) | 4.1565 | ||
| 12-1 Month Momentum % | 7.08 | ||
| 52-Week Range ($) | 2.9103 - 6.608 | ||
| Shares Outstanding (Mil) | 45.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
KORU Medical Systems Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
KORU Medical Systems Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-12 16:30 | In 128 days | ||
| Third quarter earnings results for 2026 | 2026-11-12 | In 127 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-06 16:30 | In 30 days | ||
| Second quarter earnings results for 2026 | 2026-08-06 | In 29 days | ||
| General meeting for 2026 | 2026-05-19 08:00 | 3.83 (-1.29%) | ||
| First quarter earnings conference call for 2026 | 2026-05-06 16:30 | 4.08 (+1.24%) | ||
| First quarter earnings results for 2026 | 2026-05-06 | 4.08 (+1.24%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-12 16:30 | 4.51 (+0.00%) | ||
| Annual report for 2025 | 2026-03-12 | 4.51 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-12 | 4.51 (+0.00%) |
Show
Entries
KORU Medical Systems Inc Frequently Asked Questions
What is KORU Medical Systems Inc(KRMD)'s stock price today?
The current price of KRMD is $4.44. The 52 week high of KRMD is $6.61 and 52 week low is $2.91.
When is next earnings date of KORU Medical Systems Inc(KRMD)?
The next earnings date of KORU Medical Systems Inc(KRMD) is 2026-08-06 Est..
Does KORU Medical Systems Inc(KRMD) pay dividends? If so, how much?
KORU Medical Systems Inc(KRMD) does not pay dividend.
Guru Commentaries on NAS:KRMD
No articles.
Press Release
Articles on KORU Medical Systems Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers